The PE Ratio as of December 2025 (TTM) for Diamond Biotechnology Co., Ltd (6815.TWO) is 81.98

According to Diamond Biotechnology Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 81.98. This represents a change of 184.65% compared to the average of 28.80 of the last 4 quarters.

Diamond Biotechnology Co., Ltd (6815.TWO) Historical PE Ratio (quarterly & annually)

How has 6815.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Diamond Biotechnology Co., Ltd over the last ten years is 40.91. The current 81.98 PE Ratio has changed 19.94% with respect to the historical average. Over the past ten years (40 quarters), 6815.TWO's PE Ratio was at its highest in in the June 2020 quarter at 55.73. The PE Ratio was at its lowest in in the June 2021 quarter at 7.63.

Diamond Biotechnology Co., Ltd (6815.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Diamond Biotechnology Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Diamond Biotechnology Co., Ltd (6815.TWO) Average PE Ratio

How has 6815.TWO PE Ratio performed in the past?

The current PE Ratio of Diamond Biotechnology Co., Ltd (6815.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Diamond Biotechnology Co., Ltd (6815.TWO) PE Ratio vs. Peers

How is 6815.TWO’s PE Ratio compared to its peers?

Diamond Biotechnology Co., Ltd’s PE Ratio is greater than Applied BioCode Corporation (-8.73), greater than InnoCare Optoelectronics Corporation (16.79), greater than MedFirst Healthcare Services, Inc. (16.19), less than Genovate Biotechnology Co., Ltd. (144.46), greater than Golden Biotechnology Corporation (-15.69), greater than BenQ Medical Technology Corporation (23.49), greater than DIVA Laboratories, Ltd. (21.88), greater than Medtecs International Corporation Limited (-4.49), greater than Wellell Inc. (22.61), greater than Crystalvue Medical Corporation (14.50),

Build a custom stock screener for Diamond Biotechnology Co., Ltd (6815.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diamond Biotechnology Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Diamond Biotechnology Co., Ltd (6815.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Diamond Biotechnology Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.